Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
3(43%)
Results Posted
200%(2 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
7
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
N/ANon-phased studies
7(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Recruiting3
Terminated2
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
33.3%
Most Advanced
N/A

Trials by Phase

N/A7 (100.0%)

Trials by Status

recruiting343%
completed114%
terminated229%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7